Executive Management

  • mark-augusti-491x489

    Mark Augusti, CEO

    Chief Executive Officer and President

    Mark Augusti has served as our President and Chief Executive Officer since November 2016. Prior to joining us, Mr. Augusti was Integra LifeSciences Corporation’s Corporate Vice President, and President of Orthopedics and Tissue Technologies. Mr. Augusti was responsible for the management of the Orthopedics and Tissue Technologies global division, which includes extremity implants, tissue products, and the Private Label business. His responsibilities included U.S. commercial leadership, global portfolio management, evaluation of corporate development opportunities and overall strategic direction. He joined Integra in April 2014 as Corporate Vice President and President of Orthopedics and Tissue Technologies, and brings over 25 years of executive management experience in medical technology. Prior to joining Integra, Mr. Augusti served as Chief Executive Officer at Bioventus LLC, from May 2012 to August 2013, and was a member of the company’s Board of Directors during the same period. Prior to that Mr. Augusti spent nine years with Smith & Nephew, from April 2003 to April 2012, in a series of leadership roles, including President of Smith & Nephew’s Biologic Division, where he was appointed to lead Smith & Nephew’s new biologics initiative. He also served as Smith & Nephew’s President of the Orthopaedic Trauma & Clinical Therapies Global Business and Senior Vice President and General Manager of the Trauma business. Prior to that, from 1987 to 2000, he spent 13 years at GE Medical Systems, where he held various sales, marketing and strategic management roles, both in the U.S. and internationally. Mr. Augusti received his M.B.A. from the UCLA Anderson School of Management, and his B.S. in Computer Science and Economics from Duke University.

  • Paul Weiner

    Paul Weiner, CPA

    Chief Financial Officer

    Mr Weiner has served as our Chief Financial Officer since April 2014. Prior to joining us, Mr Weiner spent 18 years at Palomar Medical Technologies, Inc., or Palomar, a company engaged in research, development, manufacturing and sales of medical laser devices for aesthetic treatments, prior to its acquisition by Cynosure, Inc. He served in a number of roles at Palomar, including corporate controller, vice president of finance and, finally, chief financial officer, a position he held for 11 years. Prior to Palomar, Mr Weiner was the chief financial officer at Hygenetics Environmental Services, Inc., an environmental consulting company, and worked in public accounting for Ernst & Young and Wolf & Company. Mr Weiner is a Certified Public Accountant and has a BSc in Accounting from Bryant University.

  • daniel_steines

    Daniel Steines, MD, MS

    Chief Technology Officer

    Dr. Steines has served as our Chief Technology Officer since June 2014. From July 2004 to June 2014, he was our Senior Vice President of Research & Development. Prior to joining us, he served as the Senior Vice President of Research & Development for ImaTx, Inc., one of our wholly-owned subsidiaries, from September 2001 to July 2004, where he was responsible for the development of image analysis applications for the diagnosis of osteoarthritis and osteoporosis. Prior to that, he held research positions at Stanford University and The Charité, Universitätsmedizin in Berlin, working in the areas of new imaging techniques to assess osteoarthritis and articular cartilage as well as novel medical video applications. Dr. Steines has an M.S. in computer science from the Technical University Berlin and an M.D. from the Technical University of Aachen.

  • david_cerveny

    David Cerveny, JD

    Chief Legal Officer and General Counsel

    Mr Cerveny has served as our Chief Legal Officer and General Counsel since October 2008. Prior to joining us, Mr Cerveny was the chief intellectual property counsel for Palomar, where he managed an extensive patent portfolio, active patent litigation and licensing strategy. He was also previously a partner at Hale and Dorr LLP, now Wilmer Cutler Pickering Hale and Dorr LLP, and an associate at Proskauer Rose LLP. Prior to his law studies, Mr Cerveny worked as a systems engineer developing flight control systems for McDonnell Douglas Corporation, an aerospace manufacturing corporation now part of The Boeing Company. Mr Cerveny has a BSc in biomedical engineering from Marquette University and a JD from Boston College Law School.

  • adam_hayden

    Adam Hayden, MS, MBA

    Senior Vice President, Sales & Marketing

    Mr Hayden has served as our Senior Vice President of Marketing since April 2015, with responsibility for international sales, product management, corporate communications, meetings and events and medical education outreach. From June 2013 to April 2015, he served as Vice President of Marketing. From May 2012 to May 2013, he led our knee product management efforts. Prior to joining us, Mr Hayden held various senior marketing positions from May 2007 to December 2011 at Smith & Nephew, a medical device company specialising in joint replacement products, including director of marketing responsible for global biomaterials franchise. From May 2002 to May 2007, he also held senior marketing positions at Johnson & Johnson’s Orthopaedic Division, now DePuy Orthopedics, Inc., or Depuy. Prior to his career in orthopaedics, Mr Hayden served as a Captain in the United States Army. Mr Hayden has a BSc in Mechanical Engineering from Cornell University, an MBA from the University of Colorado and an MS in Biomedical Engineering from the University of Michigan.

  • Rick Paxton

    Rick Paxton

    Vice President, Sales, Eastern USA, and Area Vice President, Southeast USA

    Mr Paxton has served as our Vice President of Sales, Eastern USA, since February 2014, with responsibility for all aspects of sales management for the Eastern United States regions, and Area Vice President, Southeast USA since January 2013. From April 2011 to December 2012, he was a member of the Regional Sales Management team. From February 2000 to April 2011, Mr Paxton served in various sales and sales management positions at GlaxoSmithKline plc, or GSK, a global healthcare company. Prior to GSK, Mr Paxton served as a regional sales manager at NeuroMetrix, Inc., a medical device distributor, and a sales representative in the Patient Care Division of Procter & Gamble Co., a global manufacturer of household products. Mr Paxton has a BSBA with a Business Law concentration from Western Carolina University.

  • Marc-Quartulli-329x267

    Marc Quartulli

    Vice President, Clinical Affairs

    Mr Quartulli has served as our Vice President, Clinical Affairs since April 2015. From July 2011 to March 2015, he was our Senior Director, Clinical Affairs. Prior to joining us, Mr Quartulli served as a consultant for Globus Medical from January 2011 to June 2011 following their acquisition of Facet Solutions, Inc., a manufacturer of spinal implants, where he had served as director of clinical affairs from March 2006 to December 2010. Prior to that, he served as a clinical manager at NDO Surgical, Inc. and as a senior clinical research associate at Boston Scientific. Mr Quartulli has over 18 years of experience in clinical research which began at Dana-Farber Cancer Institute, where he advanced through positions of increasing responsibility in clinical affairs roles. Mr Quartulli has a B.S. in Biology from Siena College.

  • amita

    Amita Shah, MS

    Senior Vice President, Regulatory and Quality Affairs

    Ms Shah has served as our Senior Vice President, Regulatory and Quality Affairs since August 2008, with responsibility for quality assurance and regulatory affairs functions. Prior to joining us, Ms Shah served as director of quality assurance and regulatory affairs at ESA Biosciences, Inc., a diagnostic medical device company, from January 2008 to July 2008, where she led and managed the company’s quality assurance and regulatory affairs activities. Prior to that, Ms Shah served as the director of quality affairs at Confluent Surgical Inc., a cranial and spinal sealant company. Ms Shah also has over a decade of experience in cardiovascular devices with C.R. Bard, Inc., a medical device company, where she advanced through positions of increasing responsibility in the quality assurance and regulatory affairs functions. Ms Shah has a BSc in Biology and Chemistry and an MSc in Organic Chemistry, both from Kanpur University in India, as well as a Regulatory Affairs Certificate from the Regulatory Affairs Professionals Society.

  • slammin

    John Slamin

    Senior Vice President, Knee Implant Engineering

    Mr Slamin has served as our Senior Vice President, Knee Implant Engineering since October 2007, with responsibility for overseeing all product engineering and development of our knee implants. Before joining us, Mr Slamin spent more than 30 years in research and development at Johnson & Johnson’s Orthopaedic Division, now DePuy, where he was responsible for product development activities. Mr Slamin is the holder of seven patents related to knee implant engineering. Mr Slamin has an Associate Degree in Mechanical Engineering from Wentworth Institute of Technology in Boston, Massachusetts.